Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: vaccines - Bharat Biotech

Next Previous
Drug Profile

Research programme: vaccines - Bharat Biotech

Alternative Names: Malaria vaccine - Bharat Biotech; Methicillin-resistant Staphylococcus aureus vaccine - Bharat Biotech; Non-typhoidal salmonella vaccine -Bharat Biotech; NTS conjugate vaccine - Bharat Biotech; Papilloma virus vaccine - Bharat Biotech; Pertussis vaccine - Bharat Biotech; Plasmodium vivax malaria vaccine; PvR II; PvRII/Matrix-M; Tetanus vaccine - Bharat Biotech

Latest Information Update: 28 May 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bharat Biotech
  • Developer Bharat Biotech; Center for Vaccine Development
  • Class Bacterial vaccines; Conjugate vaccines; Viral vaccines
  • Mechanism of Action Duffy antigen binding protein modulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Human papillomavirus infections; Malaria; Methicillin-resistant Staphylococcus aureus infections; Pertussis; Salmonella infections; Tetanus

Most Recent Events

  • 28 May 2024 No recent reports of development identified for preclinical development in Malaria in India (Parenteral)
  • 21 May 2022 PvR II is still in preclinical phase for Malaria (Parenteral) in India
  • 21 May 2022 University of Oxford plans a phase-II trial for Malaria (In volunteers)in Thailand (Parenteral) in September 2022 (NCT05380388)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top